Skip to Content


Dan Vergano, quoting Rachel E. Sachs (Academic Fellow Alumna)
BuzzFeed News
December 31, 2016

Read the Full Article

From the article:

The dispute “is not the first time someone has raised questions over NIH’s method of giving exclusive rights to promising drugs,” Washington University law professor Rachel Sachs told BuzzFeed News. Since the 1980’s, health policy experts have asked why the NIH, the $31 billion federal powerhouse behind the US biomedical research system, doesn’t claw back more money from the pharmaceutical industry, where profit margins are rivaled only by banking.

“Somebody has to put pressure on them,” Sachs said. “KEI is asking the right questions here.” [...]

Read the full article here.

Read the Full Article

Tags

pharmaceuticals   rachel sachs